International audienceMiniaturized devices for the extraction of DNA have been used for assessing genetic material in biological, forensic and environmental samples. However, the ability to isolate trace amounts of highly fragmented DNA from biological fluids remains a challenge. The current work reports a microfluidic approach that combines on line a dynamic magnetic extraction procedure with droplet-based digital PCR (ddPCR). This strategy maximizes the surface area for DNA binding within the chip, in order to capture short DNA fragments, with the possibility of recovering the purified samples into picoliter volumes for high sensitivity mutation detection. The application of this technology to capture circulating cell-free DNA (ccfDNA) fr...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
BACKGROUND: In cancer patients, circulating cell-free DNA (ccfDNA) can contain tumor-derived DNA (ct...
International audienceMiniaturized devices for the extraction of DNA have been used for assessing ge...
Cell-free DNA (cfDNA) is a liquid biopsy marker that can carry signatures (i.e., mutations) associat...
Cell-free DNA (cfDNA) is a liquid biopsy marker that can carry signatures (i.e., mutations) associat...
Abstract Liquid biopsy, in particular circulating tumor DNA (ctDNA) analysis, has paved the way for ...
Abstract Liquid biopsy, in particular circulating tumor DNA (ctDNA) analysis, has paved the way for ...
Genetic testing based on the analysis of circulating cell-free DNA (cfDNA) in body fluids, especiall...
Abstract Nucleic acids serve as biomarkers of disease and it is highly desirable to develop approach...
International audienceGenetic testing based on the analysis of circulating cell-free DNA (cfDNA) in ...
The potential utility of circulating tumour DNA (ctDNA) in patient blood for cancer diagnostics and ...
The potential utility of circulating tumour DNA (ctDNA) in patient blood for cancer diagnostics and ...
Multiplex amplification of DNA can be highly valuable in circulating tumor DNA (ctDNA) analysis due ...
Circulating cell-free DNA (cfDNA) is a powerful cancer biomarker for establishing targeted therapies...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
BACKGROUND: In cancer patients, circulating cell-free DNA (ccfDNA) can contain tumor-derived DNA (ct...
International audienceMiniaturized devices for the extraction of DNA have been used for assessing ge...
Cell-free DNA (cfDNA) is a liquid biopsy marker that can carry signatures (i.e., mutations) associat...
Cell-free DNA (cfDNA) is a liquid biopsy marker that can carry signatures (i.e., mutations) associat...
Abstract Liquid biopsy, in particular circulating tumor DNA (ctDNA) analysis, has paved the way for ...
Abstract Liquid biopsy, in particular circulating tumor DNA (ctDNA) analysis, has paved the way for ...
Genetic testing based on the analysis of circulating cell-free DNA (cfDNA) in body fluids, especiall...
Abstract Nucleic acids serve as biomarkers of disease and it is highly desirable to develop approach...
International audienceGenetic testing based on the analysis of circulating cell-free DNA (cfDNA) in ...
The potential utility of circulating tumour DNA (ctDNA) in patient blood for cancer diagnostics and ...
The potential utility of circulating tumour DNA (ctDNA) in patient blood for cancer diagnostics and ...
Multiplex amplification of DNA can be highly valuable in circulating tumor DNA (ctDNA) analysis due ...
Circulating cell-free DNA (cfDNA) is a powerful cancer biomarker for establishing targeted therapies...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of...
BACKGROUND: In cancer patients, circulating cell-free DNA (ccfDNA) can contain tumor-derived DNA (ct...